Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Molecular and Clinical Oncology|May 17, 2024
Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expressionMinehiko Inomata, Shuhei Minatoyama, Naoki Takata, et al.
Oncology Reports|April 4, 2012
SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in miceKensuke Suzuki, Ryuji Hayashi, Tomomi Ichikawa, et al.
In Vivo (Athens, Greece)|April 29, 2021
Case Series of Pleomorphic Carcinoma of the Lung Treated With Immune Checkpoint InhibitorsKana Hayashi, Kotaro Tokui, Minehiko Inomata, et al.
Anticancer Research|February 29, 2024
Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet ChemotherapyMinehiko Inomata, Shuhei Minatoyama, Naoki Takata, et al.
Cancer Diagnosis & Prognosis|May 5, 2025
Multicenter Retrospective Analysis of Pulmonary Sarcomatoid Carcinoma Clinically Diagnosed Using Small Biopsy SpecimensMinehiko Inomata, Takeshi Tsuda, Tomomi Ichikawa, et al.
Molecular and Clinical Oncology|April 10, 2023
Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor‑infiltrating CD68‑positive cell counts in patients with EGFR‑mutant non‑small cell lung cancerTakeshi Tsuda, Kensuke Suzuki, Minehiko Inomata, et al.
Journal of Diabetes Investigation|May 21, 2014
Visceral adipose tissue level, as estimated by the bioimpedance analysis method, is associated with impaired lung functionMinehiko Inomata, Yukio Kawagishi, Chihiro Taka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2017
[A Retrospective Study Analyzing the Clinical Course of Patients with Non-Small Cell Lung Cancer Receiving Local or Systemic Therapy after Post-Operative Recurrence]Minehiko Inomata, Hiroaki Tanaka, Kazuki Shimokawa, et al.
Respirology (Carlton, Vic.)|October 16, 2012
Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthmaTomomi Ichikawa, Ryuji Hayashi, Kensuke Suzuki, et al.
In Vivo (Athens, Greece)|April 30, 2024
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case ReportTakahiro Hirai, Minehiko Inomata, Shuhei Minatoyama, et al.
Pageof 4